Aarsland, D., Ballard, C., McKeith, I., Perry, R. H. and Larsen, J. P. (2001). Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 13, 374–379.
Abe, Y.et al. (2003). Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. Journal of Neurology Neurosurgery and Psychiatry, 74, 419–422.
Akkal, D., Dum, R. P. and Strick, P. L. (2007). Supplementary motor area and presupplementary motor area: targets of basal ganglia and cerebellar output. Journal of Neuroscience, 27, 10659–10673.
Asanuma, K.et al. (2006). Network modulation in the treatment of Parkinson's disease. Brain, 129, 2667–2678.
Ballard, C., Walker, M., O'Brien, J., Rowan, E. and McKeith, I. (2001). The characterisation and impact of “fluctuating” cognition in dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry, 16, 494–498.
Ballard, C. G.et al. (2002). Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology, 59, 1714–1720.
Bonanni, L., Thomas, A., Tiraboschi, P., Perfetti, B., Varanese, S. and Onofrj, M. (2008). EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up. Brain, 131, 690–705.
Bradshaw, J., Saling, M., Hopwood, M., Anderson, V. and Brodtmann, A. (2004). Fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease is qualitatively distinct. Journal of Neurology Neurosurgery and Psychiatry, 75, 382–387.
Colloby, S. J.et al. (2002). A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. European Journal of Nuclear Medicine and Molecular Imaging, 29, 615–622.
Colloby, S. J.et al. (2008). A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies. International Psychogeriatrics, 20, 1124–1140.
Colloby, S. J.et al. (2013). Multivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer's disease: utility in differential diagnosis. Journal of Cerebral Blood Flow and Metabolism, 33, 612–618.
Donders, F. C. (1869). On the speed of mental processes. In Koster, W. G. (ed.), Attention and Performance II. Acta Psychologica, 30, 412–431. (Original work published in 1868.)
Eckert, T., Tang, C. and Eidelberg, D. (2007a). Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurology, 6, 926–932.
Eckert, T.et al. (2007b)). Quantification of Parkinson's disease-related network expression with ECD SPECT. Journal of Nuclear Medicine and Molecular Imaging, 34, 496–501.
Eidelberg, D.et al. (1995). Assessment of disease severity in Parkinsonism with fluorine-18-fluorodeoxyglucose and PET. Journal of Nuclear Medicine, 36, 378–383.
Ferman, T. J.et al. (2004). DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology, 62, 181–187.
Franciotti, R.et al. (2013). Default network is not hypoactive in dementia with fluctuating cognition: an Alzheimer disease/dementia with Lewy bodies comparison. Neurobiology of Aging, 34, 1148–1158.
Francis, P. T., Perry, E. K., Piggott, M. A. and Duda, J. E. (2006). Neurochemical pathology of dementia with Lewy bodies. In O'Brien, J. T., Mckeith, I. G., Ames, D. and Chiu, E. (eds.), Dementia with Lewy Bodies and Parkinson's Disease Dementia (pp. 167–176). Oxon: Taylor and Francis Group.
Gene, E. and Alexander, J. R. M. (1994). Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: a principal component approach to modeling brain function in disease. Human Brain Mapping, 2, 79–94.
Habeck, C.et al. (2005). A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural Computing, 17, 1602–1645.
Hirano, S., Eckert, T., Flanagan, T. and Eidelberg, D. (2009). Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease. Movement Disorders, 24 (Suppl. 2), S725–S731.
Huang, C., Mattis, P., Tang, C., Perrine, K., Carbon, M. and Eidelberg, D. (2007). Metabolic brain networks associated with cognitive function in Parkinson's disease. NeuroImage, 34, 714–723.
Jones, C. R., Malone, T. J., Dirnberger, G., Edwards, M. and Jahanshahi, M. (2008). Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease. Brain and Cognition, 68, 30–41.
Kessels, R. P., Mimpen, G., Melis, R. and Rikkert, M. G. (2009). Measuring impairments in memory and executive function in older people using the Revised Cambridge Cognitive Examination. American Journal of Geriatric Psychiatry, 17, 793–801.
Lozza, C., Baron, J. C., Eidelberg, D., Mentis, M. J., Carbon, M. and Marie, R. M. (2004). Executive processes in Parkinson's disease: FDG-PET and network analysis. Human Brain Mapping, 22, 236–245.
Macar, F., Coull, J. and Vidal, F. (2006). The supplementary motor area in motor and perceptual time processing: fMRI studies. Cognitive Processing, 7, 89–94.
McKeith, I. G.et al. (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology, 47, 1113–1124.
McKeith, I.et al. (2000). Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet, 356, 2031–2036.
McKeith, I. G.et al. (2005). Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology, 65, 1863–1872.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939–944.
Mesulam, M.-M. (1981). A cortical network for directed attention and unilateral neglect. Annals of Neurology, 10, 309–325.
Middleton, F. A. and Strick, P. L. (2000). Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Research Reviews, 31, 236–250.
O'Brien, J. T., Firbank, M. J., Mosimann, U. P., Burn, D. J. and McKeith, I. G. (2005). Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies. Psychiatry Research, 139, 79–88.
Pastor, M. A., Artieda, J., Jahanshahi, M. and Obeso, J. A. (1992). Time estimation and reproduction is abnormal in Parkinson's disease. Brain, 115, 211–225.
Perry, E., Walker, M., Grace, J. and Perry, R. (1999). Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends in Neuroscience, 22, 273–280.
Picard, N. and Strick, P. L. (2003). Activation of the supplementary motor area (SMA) during performance of visually guided movements. Cerebral Cortex, 13, 977–986.
Piggott, M. A., Ballard, C. G., Dickinson, H. O., McKeith, I. G., Perry, R. H. and Perry, E. K. (2007). Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. International Journal of Neuropsychopharmacology, 10, 231–244.
Pimlott, S. L.et al. (2006). Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. Neurobiology of Disease, 21, 50–56.
Posner, M. I., Cohen, Y. and Rafal, R. D. (1982). Neural systems control of spatial orienting. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences, 298, 187–198.
Rafal, R. D., Posner, M. I., Friedman, J. H., Inhoff, A. W. and Bernstein, E. (1988). Orienting of visual attention in progressive supranuclear palsy. Brain, 111, 267–280.
Rowe, J., Stephan, K. E., Friston, K., Frackowiak, R., Lees, A. and Passingham, R. (2002). Attention to action in Parkinson's disease: impaired effective connectivity among frontal cortical regions. Brain, 125, 276–289.
Steriade, M. (2006). Grouping of brain rhythms in corticothalamic systems. Neuroscience, 137, 1087–1106.
Teki, S., Grube, M. and Griffiths, T. D. (2011). A unified model of time perception accounts for duration-based and beat-based timing mechanisms. Frontiers in Integrative Neuroscience, 5, 90.
Walker, M. P.et al. (2000a). The clinician assessment of fluctuation and the one day fluctuation assessment scale. Two methods to assess fluctuating confusion in dementia. British Journal of Psychiatry, 177, 252–256.
Walker, M. P.et al. (2000b)). Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dementia Geriatric and Cognitive Disorders, 11, 327–335.
Weissman, D. H., Roberts, K. C., Visscher, K. M. and Woldorff, M. G. (2006). The neural bases of momentary lapses in attention. Nature Neuroscience, 9, 971–978.
Wesnes, K. A.et al. (2002). Effects of rivastigmine on cognitive function in dementia with Lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dementia Geriatric and Cognitive Disorders, 13, 183–192.
Whitwell, J. L.et al. (2007). Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain, 130, 708–719.
Winterer, G., Adams, C. M., Jones, D. W. and Knutson, B. (2002). Volition to action – an event-related fMRI study. NeuroImage, 17, 851–858.